Literature DB >> 20664346

Colorectal cancer screening.

Randall W Burt1.   

Abstract

PURPOSE OF REVIEW: The review will summarize the state of the art in colon cancer screening. Recently published screening guidelines will be reviewed so physicians can understand them and how to deal with the differences. Each screening modality presently in use will then be reviewed with emphasis on efficacy and problems. RECENT
FINDINGS: During the past two decades research has clearly demonstrated colon cancer screening to be effective. New modalities such as virtual colonoscopy and stool DNA screening have been introduced and are recommended by some organizations but not others. Ages to discontinue screening have also been suggested. Fecal immunochemical testing exhibits some advantages over guaiac-based testing. Problematic issues with the effectiveness of colonoscopy have arisen, particularly in the proximal colon. Both technical and biological reasons have been suggested for this decrease in effectiveness.
SUMMARY: Colon cancer screening is effective and continues to improve. Refinements of guidelines as well as refinements in each screening modality have occurred. Several screening tools are newly available and quality studies and efforts for present and new tests are imperative.

Entities:  

Mesh:

Year:  2010        PMID: 20664346     DOI: 10.1097/MOG.0b013e32833d1733

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  14 in total

Review 1.  Screening for colorectal cancer: established and emerging modalities.

Authors:  Nikhil Pawa; Tan Arulampalam; John D Norton
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-01       Impact factor: 46.802

2.  Morning colonoscopies are associated with improved adenoma detection rates.

Authors:  Tze Yeong Teng; Shao Nan Khor; Manimegalai Kailasam; Wei Keat Cheah; Cheryl Chien Li Lau
Journal:  Surg Endosc       Date:  2015-07-22       Impact factor: 4.584

3.  Referrals for suspected hematologic malignancy: a survey of primary care physicians.

Authors:  Gregory A Abel; Christopher R Friese; Bridget A Neville; Katherine M Wilson; B Taylor Hastings; Craig C Earle; Nancy L Keating; Lisa C Richardson
Journal:  Am J Hematol       Date:  2012-03-31       Impact factor: 10.047

Review 4.  Colorectal cancer screening in countries of European Council outside of the EU-28.

Authors:  Emma Altobelli; Francesco D'Aloisio; Paolo Matteo Angeletti
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

5.  A comparative examination of colorectal cancer burden in European Union, 1990-2019: Estimates from Global Burden of Disease 2019 Study.

Authors:  Rajesh Sharma
Journal:  Int J Clin Oncol       Date:  2022-05-20       Impact factor: 3.850

6.  Identification and verification of heat shock protein 60 as a potential serum marker for colorectal cancer.

Authors:  Céline Hamelin; Emilie Cornut; Florence Poirier; Sylvie Pons; Corinne Beaulieu; Jean-Philippe Charrier; Hader Haïdous; Eddy Cotte; Claude Lambert; Françoise Piard; Yasemin Ataman-Önal; Geneviève Choquet-Kastylevsky
Journal:  FEBS J       Date:  2011-11-03       Impact factor: 5.542

7.  High C-reactive protein level is associated with high-risk adenoma.

Authors:  Hyae Min Lee; Jae Myung Cha; Jung Lok Lee; Jung Won Jeon; Hyun Phil Shin; Kwang Ro Joo; Jin Young Yoon; Joung Il Lee
Journal:  Intest Res       Date:  2017-10-23

8.  Assessment of Serosal Invasion and Criteria for the Classification of Pathological (p) T4 Staging in Colorectal Carcinoma: Confusions, Controversies and Criticisms.

Authors:  Colin J R Stewart; Simon Hillery; Cameron Platell; Giacomo Puppa
Journal:  Cancers (Basel)       Date:  2011-01-04       Impact factor: 6.639

9.  Discovery and validation of new potential biomarkers for early detection of colon cancer.

Authors:  Xavier Solé; Marta Crous-Bou; David Cordero; David Olivares; Elisabet Guinó; Rebeca Sanz-Pamplona; Francisco Rodriguez-Moranta; Xavier Sanjuan; Javier de Oca; Ramon Salazar; Victor Moreno
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

10.  Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients.

Authors:  S N Kehlet; R Sanz-Pamplona; S Brix; D J Leeming; M A Karsdal; V Moreno
Journal:  Sci Rep       Date:  2016-07-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.